The FDA proposal would simplify registration for hub-and-spoke manufacturing networks and clarify requirements for certain foreign drug suppliers.  The FDA has proposed updated registration rules for drug manufacturers to better reflect how medicines are made today. Some ingredients pass through several foreign sites before reaching the US, while newer hub-and-spoke manufacturing networks may have to […]